HOME >> MEDICINE >> NEWS
UK and other European countries should introduce universal childhood hepatitis B vaccination

most effective means of reducing the global burden of a particular disease. It also protects children before they are at risk of infection, and vaccines available today can immunise individuals for life with no need for additional booster vaccinations. Disadvantages include cost-effectiveness in countries of low endemicity and concerns about adding another vaccine into the childhood vaccination programme.

The advantages of the at-risk strategy are that an immediate impact within the target group can be obtained, with low cost in countries with low endemicity. Disadvantages include leaving the general population at risk, the difficulties in properly identifying at risk groups and the social stigma of being defined at-risk.

The authors conclude that on the basis of current experience and evidence, the UK, Ireland, Finland, Iceland, the Netherlands, Norway, Sweden, and Denmark should all adopt a universal vaccination policy.

They say: Global hepatitis B universal vaccination is ultimately the only way to eliminate HBV transmission and new cases of hepatitis B. Indeed, global efforts to control and prevent hepatitis B are of crucial importance and it is the responsibility of each country worldwide to play its part.


'"/>

Contact: Dr. Jane Zuckerman
j.zuckerman@medsch.ucl.ac.uk
44-779-887-6445
Lancet
5-Jun-2007


Page: 1 2

Related medicine news :

1. Chemotherapy with bevacizumab increases risk of blood clots in arteries
2. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
3. Borderline personality disorder shows improvements with intensive psychotherapy
4. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
5. Chemotherapy may enhance the effectiveness of brain tumor vaccines
6. Brain-boosting pill alleviates post-chemotherapy fogginess
7. Adding radioimmunotherapy to chemo may help patients with lymphoma
8. Pre-operative chemotherapy does not increase survival rates for nonsmall cell lung cancer
9. Medical management of another condition may not lead to early cancer diagnosis
10. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
11. New mothers often not asked about depression, UNC survey finds

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... April 21, 2017 , ... The Patient Advocacy Community of The Beryl ... 2017 Ruth Ravich Patient Advocacy Award in recognition of her extraordinary contributions ... with the award at The Beryl Institute’s annual Patient Experience Conference on ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Alive ... people who wish to overcome their mental health struggles. The Alive team uses ... LeBouthillier says: “Our approach in dealing with a mental health struggle is based on ...
(Date:4/21/2017)... Ramon, CA (PRWEB) , ... April 21, 2017 , ... ... might not understand the estate planning process, or where to even begin. “Now more ... unresolved if you are to properly protect yourself and your family,” said attorney Lisa ...
(Date:4/21/2017)... ... April 21, 2017 , ... During April 21-23, Super-Sod will join the ... festival offers entertainment for everyone — from the avid gardener to the landscape admirer ... high quality event held in a grand venue, and we are certainly looking forward ...
(Date:4/21/2017)... ... April 21, 2017 , ... MiracleFeet announced today ... years to help end the disability caused by untreated clubfoot in low-income countries. ... Global Clubfoot Initiative to end disability caused by clubfoot worldwide. , ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device ... markets with innovative and proprietary products, will release financial ... after the market close on Tuesday, May 2, 2017. ... call and webcast to discuss its financial results the ... p.m. Eastern Time (3:30 p.m. Central Time). Darin ...
(Date:4/18/2017)... -- Astute Medical, Inc., developer of biomarkers for better healthcare, ... the 2017 National Kidney Foundation (NKF) Spring Clinical ... 22. Physicians will present data on two biomarkers, ... acute kidney injury (AKI) during the management of patients ... Elevated levels of TIMP-2 and IGFBP-7 have been shown ...
Breaking Medicine Technology:
Cached News: